Medications · Metabolic & weight

Compounded Tirzepatide

Dual GIP/GLP-1 receptor agonist for metabolic care.

What it does

What Compounded Tirzepatide is and why doctors prescribe it.

Tirzepatide is a dual GIP/GLP-1 receptor agonist. The manufactured supply (FDA-approved as Mounjaro for type 2 diabetes and Zepbound for chronic weight management) shows substantial weight loss and glycemic improvement. Compounded tirzepatide is dispensed under 503A in specific shortage and patient-specific contexts on a doctor's prescription.

How it works

Mechanism in plain English.

Tirzepatide activates both GIP and GLP-1 receptors. The dual mechanism amplifies glucose-dependent insulin release, slows gastric emptying, suppresses glucagon, and reduces appetite via central pathways. Clinical outcomes have shown larger average weight loss than GLP-1 monotherapy in head-to-head comparisons.

How long it's been studied

Research history.

Tirzepatide was first studied clinically in the late 2010s and received FDA approval in 2022 for type 2 diabetes and 2023 for weight management. Cardiovascular-outcome and broader metabolic studies continue. Compounded availability has tracked FDA shortage status and regulatory determinations.

Dosing

Clinical context for the prescribing doctor.

Doctor-prescribed and titrated. Subcutaneous injectable dosing is typically initiated at the lowest strength and titrated upward based on tolerance, glycemic response, and weight progress at the doctor's discretion. Compounded drugs are not FDA-approved and should not be evaluated using branded-drug trial data.

This page is informational, not a dispensing aid. Compounded Tirzepatide is dispensed only on a patient-specific prescription written by a licensed doctor for an identified patient. Compounded drugs are not FDA-approved and should not be evaluated using branded-drug trial data. Availability varies by state and prescribed medication.

How to access Compounded Tirzepatide through RonanRx

Three paths.

Doctors can prescribe compounded Compounded Tirzepatide for individual patients through RonanRx. Patients with a doctor can sign up to receive their prescription. Patients without a doctor can learn how the referral works.

For doctors

Request a partnership call.

A pharmacist will follow up within two business days. We'll cover state availability, supported formulations, and what integration looks like for your clinic.

Request partnership call →

Patient with a doctor

Sign up to receive your prescription.

If your doctor has already prescribed Compounded Tirzepatide, sign up so we can prepare and ship your medication. The signup wizard collects intake and connects you to the prescribing workflow.

Sign up →

Patient without a doctor

Get referred by a partner clinic.

RonanRx prescribes through partner clinics — we don't initiate prescriptions on this site. Read how the referral process works and how to find a partner clinic in your state.

For patients →